Raising a seed round in 2025 is simultaneously more standardized and more nuanced than it has ever been. The market has matured. Founders have better information. Investors have sharper pattern recognition. And yet the gap between founders who understand the machinery of a seed round and those who do not remains remarkably wide. This article is an attempt to close that gap.
At Curevstone Capital, we lead or co-lead $5M seed rounds. We see hundreds of companies per year, and we spend a meaningful portion of our partner time helping founders who are in process understand what they are actually agreeing to. What follows is the framework we use internally, shared publicly because we believe informed founders make better long-term partners.
SAFEs Versus Priced Equity Rounds: The Decision That Shapes Everything
The first structural decision in any seed round is whether to raise on a Simple Agreement for Future Equity (SAFE) or to conduct a priced equity round. This is not a cosmetic choice. It has real consequences for governance, dilution timing, investor expectations, and your Series A process.
SAFEs, introduced by Y Combinator in 2013 and updated in 2018, have become the dominant instrument for early seed financings. They are convertible instruments that do not create immediate equity or a debt obligation. A SAFE converts to equity at a future priced round, typically Series A, at terms defined at the time of the SAFE issuance. The primary variables are the valuation cap and the discount rate.
Priced rounds, by contrast, establish a formal company valuation today. They involve the issuance of preferred stock, a full set of legal documents (Certificate of Incorporation amendment, Stock Purchase Agreement, Investor Rights Agreement, Right of First Refusal and Co-Sale Agreement, Voting Agreement), and typically a board seat or board observer right for the lead investor. They cost more to execute, typically $25,000 to $50,000 in legal fees versus $5,000 to $15,000 for a SAFE round, and they take longer to close.
For most seed-stage companies in 2025, the SAFE is the right instrument if the round is below $3M and the company is pre-product or very early post-launch. Once you are raising $3M or above, once you have institutional investors at the table, or once you are seeking board-level governance engagement, a priced round becomes the more appropriate vehicle. A $5M seed round from a firm like ours almost always comes as a priced Series Seed preferred round.
2025 Seed Valuations: What the Market Actually Looks Like
The frothy valuations of 2021 and early 2022 compressed sharply through 2023 and have stabilized at more defensible levels. In 2025, a typical pre-money valuation for a seed round with genuine traction ranges from $15M to $25M. Companies at the lower end of that range typically have a working prototype, early customer conversations, and a founding team with relevant domain experience. Companies at the upper end have demonstrated some form of early revenue, meaningful user engagement, or a genuinely differentiated technical capability.
Outliers exist in both directions. An AI infrastructure company with a technical founder who previously built a relevant system at a top-tier research lab may command a $30M or $35M pre-money valuation. A consumer app with no clear monetization path may struggle to clear $10M. The market has grown considerably more discriminating.
Post-money valuation is what matters for dilution math. A $5M round at $20M pre-money produces a $25M post-money valuation and implies 20% dilution for the new investors. That is at the high end of the acceptable range. A $5M round at $25M pre-money produces $30M post-money and 16.7% dilution, which is more comfortable. The difference between a $20M and $25M pre-money valuation is not merely academic. It affects how much ownership the founding team retains going into Series A and how much room exists for a meaningful employee option pool.
Dilution Targets and Option Pool Construction
A well-structured seed round aims to leave founders and the employee option pool collectively owning roughly 70% to 75% of the company on a fully diluted basis after close. That means new investors should own no more than 15% to 20% in aggregate. If you are raising $5M from a single lead investor, you are targeting that lead at 15% to 18% of the post-round cap table.
Option pool construction deserves careful attention. Investors will typically request that the option pool be established or refreshed prior to the pricing of the round, which means option pool dilution falls on existing shareholders, not new investors. The standard ask is a 10% to 15% post-financing option pool. Founders should push back on option pools sized larger than necessary to cover the next 18 to 24 months of hiring. An unnecessarily large pool increases founder dilution without providing corresponding benefit.
Build a detailed hiring plan and use it to justify the pool size. If your 24-month hiring plan requires 12 option pool positions and your average grant is 0.3%, you need 3.6% of the post-round company in new options. That is very different from accepting a 15% pool on the lead's boilerplate term sheet. The negotiation here is real and the stakes are meaningful.
SAFE Mechanics: Caps, Discounts, and the MFN Clause
For founders still in the SAFE phase, either because they raised a pre-seed on SAFEs or because their current seed round will be structured as SAFEs prior to a larger priced round, it is worth understanding the mechanics in detail.
The valuation cap sets the maximum valuation at which a SAFE converts. If you issued a SAFE with a $10M cap and you subsequently raise a priced round at a $25M pre-money valuation, the SAFE holder converts at the $10M cap, not the $25M priced valuation. This rewards early risk-takers and aligns incentives for investors who committed capital when the company was nascent.
The discount rate is a simpler mechanism. A 20% discount means the SAFE holder converts at 80% of the price per share paid by new investors in the priced round. On a $2 per share Series A, a SAFE with a 20% discount converts at $1.60 per share. Many SAFEs include both a cap and a discount, and the holder receives whichever results in a lower conversion price, i.e., whichever is more favorable to them.
The Most Favored Nation (MFN) clause, used primarily in uncapped SAFEs, grants the SAFE holder the right to convert on the same terms as the most favorable SAFE issued to any subsequent investor. If you issue an MFN SAFE today and later issue a capped SAFE at a $12M cap, the MFN holder can opt into that $12M cap. Founders should understand that MFN clauses create ongoing obligations that can complicate later financing negotiations if not tracked carefully.
Board Composition at the Seed Stage
In a priced seed round, the question of board composition is not procedural. It is strategic. The typical arrangement for a $5M seed round is a three-person board: two founder seats and one investor seat held by the lead. This is the configuration we use at Curevstone Capital for our seed investments.
Some term sheets will propose a five-person board with two founders, one investor, and two independent directors to be designated by mutual consent. This structure can work well if the founders have strong candidate networks for independent directors, but it can also stall if no suitable candidates emerge. We generally recommend deferring the five-person structure until Series A, when the company has more operating history and a clearer sense of what board-level expertise it actually needs.
What founders sometimes underestimate is how much the board composition at seed influences the dynamics at Series A. If your seed lead takes a board seat and your Series A lead also takes a board seat, you may find yourself in a minority position on your own board with a five-person structure before you have hired any independent directors. Plan this architecture deliberately.
Pro-Rata Rights: Why They Matter More Than Founders Think
Pro-rata rights give an investor the right to participate in future financing rounds up to their pro-rata share, maintaining their percentage ownership. For a seed investor who owns 15% of the company, pro-rata rights mean the right to invest 15% of any subsequent financing round at the same terms as new investors.
Founders often view pro-rata rights as a minor concession to investors. They are not. Pro-rata rights are among the most economically significant provisions in any seed term sheet. Here is why: a seed investor who writes a $5M check into a company that grows to a $500M Series B has an enormous financial incentive to exercise their pro-rata. The returns at the seed entry price are orders of magnitude higher than returns from later-stage entry. Strong pro-rata rights are how top seed funds generate outsized returns on their winners.
From the founder's perspective, pro-rata rights constrain the available allocation at future rounds. A Series A investor who wants to own 20% of the company may find their allocation reduced by the exercise of seed-stage pro-rata rights. This can create friction in Series A negotiations. It can also be a positive signal: a seed investor who exercises their pro-rata is vouching publicly for the company, which has real signaling value to new investors.
The most common structure we see in 2025 is a major investor pro-rata right that applies to investors above a certain ownership threshold, typically 5%, and a super pro-rata right that grants the lead investor the right to participate in future rounds above their pro-rata share. Founders should push back firmly on super pro-rata rights, as they can give a single investor disproportionate influence over future round economics.
Information Rights and Reporting Obligations
Investor Rights Agreements in priced seed rounds typically include information rights: the right to receive quarterly financial statements, annual audited financials (or in some cases unaudited financials with a commitment to audit at Series A), and board materials in advance of board meetings. They may also include the right to inspect the company's books and records upon reasonable notice.
Information rights are not purely administrative. They establish a cadence of accountability that shapes the investor-founder relationship for the life of the investment. Founders who are transparent and disciplined in their reporting build trust. Founders who are intermittent or opaque create anxiety and, ultimately, investor activism at inopportune moments.
We recommend treating information rights not as a burden but as an operating discipline. A monthly one-page update to investors, even when not contractually required, does more for investor relations than quarterly formal reports delivered reluctantly. The founders who do this well find that investors become genuine resources, making introductions, flagging competitive intelligence, and advocating internally for follow-on investment.
Ten Term Sheet Provisions Founders Should Push Back On
Not all term sheets are created equal. Below are ten provisions that appear in seed term sheets with some regularity and that founders are generally justified in resisting or renegotiating.
1. Participating Preferred Stock
Participating preferred allows investors to receive their liquidation preference and then also participate pro-rata in the remaining proceeds. Non-participating preferred, where investors choose either their liquidation preference or their pro-rata share, is the market standard at seed. Resist participating preferred strongly, as it significantly reduces founder economics in all but the largest exit scenarios.
2. Cumulative Dividends
A provision that accrues an 8% annual dividend on the invested capital, payable upon a liquidation event, can materially inflate the effective liquidation preference over time. Standard seed terms include non-cumulative dividends payable only if declared by the board, which in practice means they are never declared.
3. Full Ratchet Anti-Dilution
Anti-dilution provisions protect investors against down rounds. Full ratchet anti-dilution reprices the investor's shares to the lower price of any subsequent financing, regardless of the size of the down round. Weighted average anti-dilution, which takes into account both the magnitude of the price decrease and the number of new shares issued, is far more founder-friendly and is the market standard.
4. Redemption Rights
Provisions allowing investors to demand their money back after a certain period, typically five to seven years, can force a liquidity event at an inopportune time. Redemption rights are rare in seed rounds but do appear occasionally. Push back firmly.
5. Drag-Along Rights Without Founder Protections
Drag-along provisions allow a majority of shareholders to compel all shareholders to vote in favor of a sale. They are reasonable in principle but should include founder-protective thresholds: the drag should not be triggered without approval from the common shareholders as a class, not merely the preferred majority.
6. Pay-to-Play Without Carve-Outs
Pay-to-play provisions penalize investors who fail to participate in future rounds, converting their preferred stock to common. They can be useful mechanisms for discouraging passive investors who do not support the company through future financings, but they should include carve-outs for investors who are unable to participate due to fund lifecycle constraints.
7. Overly Broad Protective Provisions
Protective provisions give preferred stockholders veto rights over certain company actions. Standard protective provisions cover things like authorizing new stock, changing the rights of preferred, or liquidating the company. Overly broad versions extend to hiring above a certain compensation threshold, entering into contracts above a dollar value, or changing the business plan. Push back on anything beyond the standard list.
8. Founder Vesting Acceleration That Is Too Narrow
Double-trigger acceleration, where founder vesting accelerates upon both a change of control and an involuntary termination, is standard and appropriate. Single-trigger acceleration, where vesting accelerates on a change of control alone, is actually negotiated in favor of founders; some investors resist it. Founders should ensure double-trigger protection is explicit and well-defined.
9. Excessive Legal Fee Caps
It is standard for the company to pay the lead investor's legal fees up to a capped amount. The market standard in 2025 for a seed round is $15,000 to $25,000. Term sheets that propose no cap or a cap above $35,000 warrant pushback.
10. Broad Indemnification Provisions
Founder indemnification provisions that go beyond standard officer and director indemnification, or that attempt to hold founders personally liable for breaches of representations and warranties, are rare but do appear. Read these carefully and push back on anything that creates personal liability for good-faith business decisions.
Evaluating Competing Offers
The fortunate problem of having multiple term sheets simultaneously is one that every founder should be prepared for, not because it is guaranteed, but because preparation changes how you run the process. When comparing competing offers, resist the temptation to optimize purely on valuation. A $2M higher pre-money valuation from a less engaged investor is almost never better than a fair valuation from a partner who will actually help you.
The dimensions worth evaluating carefully are: the lead partner's personal investment track record and their typical post-investment engagement level; the firm's reserves policy and their historical follow-on behavior; the quality and relevance of their portfolio network to your hiring and customer development needs; and the specific human being who will sit on your board or serve as your primary contact.
Ask for references. Not the references the firm provides you with, but the portfolio founders you find yourself when you look at their portfolio page. Call the companies that did not work out as well as the ones that did. The way a firm behaves when a portfolio company is struggling tells you more than the way they behave when everything is going well.
The Timeline: From First Meeting to Wire
For a $5M priced seed round with an institutional lead, a realistic timeline from first meeting to money in the bank runs eight to fourteen weeks. The sequence looks roughly like this:
Weeks one and two are typically initial partner meetings and follow-up due diligence calls. The firm is evaluating the market, the technology, the team, and the competitive landscape. This is also when reference checks on the founding team are typically conducted, though more discreetly than founders often realize.
Week three or four usually brings a partner meeting, where the lead partner presents the investment to the full partnership. This is the internal moment where the deal either advances or dies. Founders are sometimes invited to present directly to the partnership; if offered, accept.
Assuming a positive partnership meeting, a term sheet typically arrives within five to ten business days. Once a term sheet is signed, the formal due diligence process begins: legal review, financial model review, technical assessment if relevant, and background checks. This takes two to four weeks for a well-prepared company.
Legal documentation follows due diligence. For a priced round, expect two to three weeks for documentation assuming both sides are using experienced counsel who know the standard forms. First-time founders often underestimate how much their own legal preparation affects this timeline. Have your cap table clean, your IP assignments executed, your corporate documents organized, and your employment agreements in place before you enter a process.
The wire typically arrives within two to five business days of final document execution. Celebrate briefly, then get back to building. The seed round is not the milestone. It is the fuel for reaching the milestones that actually matter.
The founders who navigate seed rounds most effectively are the ones who treat the process as a mutual evaluation, not a one-sided pitch. They come prepared, they ask good questions, and they choose partners as carefully as investors choose them.
A Note on Closing Conditions and What Can Go Wrong
Signed term sheets are not binding on the investment itself, only on the no-shop provision and any break-up fee. Between term sheet and close, deals can fall apart due to due diligence findings, changes in market conditions, co-investor dynamics, or simply a shift in the lead partner's conviction. The probability of a deal closing after a term sheet is high but not certain, and founders should continue other investor conversations until documents are signed and the wire is confirmed.
Common causes of post-term-sheet failure include: undisclosed cap table complexity (prior SAFEs, convertible notes, or option grants that were not disclosed upfront); IP ownership issues (code written by contractors without proper assignment, prior employer claims, or open-source license contamination); reference checks that surface concerns about the founding team's integrity or judgment; and co-investor disagreements on valuation or terms that cannot be resolved.
The best mitigation for all of these is radical transparency from the outset. Disclose everything in your data room that you would not want discovered later. Handle the uncomfortable conversations early. Investors who learn about problems from you rather than through discovery are far more likely to work through them constructively.
Raising a seed round is hard. It is time-consuming, emotionally demanding, and distracting from the work of building the company. But it is also a moment when the architecture of your company's ownership and governance is being set in ways that will persist for years. Approach it with the same rigor you bring to your product. The term sheet you sign today will still be governing the relationship between you and your investors when you sell the company or take it public a decade from now.